The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
Mengmeng Song(China Pharmaceutical University), Hanping Shi(Beijing Shijitan Hospital), Guo‐Tian Ruan(Beijing Friendship Hospital), Shiqi Lin(Nanjing University of Information Science and Technology), Hongxia Xu(Kunming University of Science and Technology), Yu Xu(Chinese Academy of Sciences), Hailun Xie(Guangxi Medical University), Chunhua Song(Zhengzhou University), Heyang Zhang(Academy of Military Medical Sciences), Kangping Zhang(Capital Medical University), Wei Li(Jilin University), Qi Zhang(Jiamusi University), Tong Liu(Second Hospital of Tianjin Medical University), Xi Zhang(Shanghai Jiao Tong University), Xiangrui Li(Institute of Plant Protection), Xiaoyue Liu(Capital Medical University), Kunhua Wang(Yunnan University), Qinqin Li(Capital Medical University), Ming Yang(Jiangsu University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Meng Tang(Capital Medical University)
Cited by 170
Related Papers
Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
|Oncogenesis|2016|259
Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
|Carcinogenesis|2013|256
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
|Proceedings of the National Academy of Sciences|1996|226